A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Dulaglutide
Related studies linked through entity extraction aliases.
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
- Status
- TERMINATED
- Phase
- PHASE3
Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- Status
- COMPLETED
- Phase
- NA
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
- Status
- UNKNOWN
- Phase
- PHASE4
A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Status
- COMPLETED
- Phase
- PHASE3
Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
- Status
- COMPLETED
- Phase
- PHASE3